Recurrent HNSCC Harbor an Immunosuppressive Tumor Immune Microenvironment Suggesting Successful Tumor Immune Evasion.
Christian WatermannHelen PasternackChristian IdelJohannes BrägelmannPatrick KupplerAnne OffermannDanny JonigkMark Philipp KühnelAndreas SchröckEva DreyerJacqueline NathansenAnna DubrovskaLars TharunJutta KirfelBarbara WollenbergSven PernerRosemarie KruparPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
HNSCC RTs have an immunosuppressive TIME, which is particularly apparent after adjuvant CRT and might substantially contribute to poor therapeutic response and prognosis.
Keyphrases